Urinary vimentin mRNA as a potential novel biomarker of renal fibrosis

American Journal of Physiology - Renal Physiology

Volumn 309, Issue 6, 2015, Pages F514-F522

  Cao, Yu Han ^a   Lv, Lin Li ^a   Zhang, Xu ^b   Hu, Hong ^c   Ding, Li Hong ^a   Yin, Di ^b   Zhang, Ying Zi ^c   Ni, Hai Feng ^a   Chen, Ping Sheng ^a   Liu, Bi Cheng ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b TAIXING PEOPLE'S HOSPITAL   (China)

^c JIANGYIN PEOPLE S HOSPITAL   (China)

Author keywords

Biomarker; Renal tubulointerstitial fibrosis; Urinary mRNA; VIM; Vimentin

Indexed keywords

CREATININE; MESSENGER RNA; VIMENTIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY FUNCTION; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEINURIA; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; TRAINING; UREA NITROGEN BLOOD LEVEL; URINALYSIS; URINE; BIOSYNTHESIS; CHRONIC KIDNEY FAILURE; FIBROSIS; HIGH THROUGHPUT SCREENING; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TEST; METABOLISM; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY;

ADULT; BIOMARKERS; FEMALE; FIBROSIS; GLOMERULAR FILTRATION RATE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; ROC CURVE; VIMENTIN;

EID: 84941670621     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00449.2014     Document Type: Article

References (26)

1. An WS, Kim HJ, Cho KH, Vaziri ND. Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney. Am J Physiol Renal Physiol 297: F895–F903, 2009.
2. Boor P, Ostendorf T, Floege J. Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 6: 643–656, 2010.
3. Grande MT, Lopez-Novoa JM. Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat Rev Nephrol 5: 319–328, 2009.
4. Hertig A, Verine J, Mougenot B, Jouanneau C, Ouali N, Sebe P, Glotz D, Ancel PY, Rondeau E, Xu-Dubois YC. Risk factors for early epithelial to mesenchymal transition in renal grafts. Am J Transplant 6: 2937–2946, 2006.
5. Hinz B. The myofibroblast: paradigm for a mechanically active cell. J Biomech 43: 146–155, 2010.
6. Iwano M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens 13: 279–284, 2004.
7. Kaissling B, Le Hir M. The renal cortical interstitium: morphological and functional aspects. Histochem Cell Biol 130: 247–262, 2008.
8. Lee JR, Muthukumar T, Dadhania D, Ding R, Sharma VK, Schwartz JE, Suthanthiran M. Urinary cell mRNA profiles predictive of human kidney allograft status. Immunol Rev 258: 218–240, 2014.
9. Li B, Hartono C, Ding R, Sharma VK, Ramaswamy R, Qian B, Serur D, Mouradian J, Schwartz JE, Suthanthiran M. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 344: 947–954, 2001.
10. Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7: 684–696, 2011.
11. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 69: 213–217, 2006.
12. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17: 2937–2944, 2006.
13. Ohnuki K, Umezono T, Abe M, Kobayashi T, Kato M, Miyauchi M, Yamamoto N, Kimura M, Toyoda M, Suzuki D. Expression of transcription factor Snai1 and tubulointerstitial fibrosis in progressive nephropathy. J Nephrol 25: 233–239, 2012.
14. Rastaldi MP, Ferrario F, Giardino L, Dell’Antonio G, Grillo C, Grillo P, Strutz F, Muller GA, Colasanti G, D’Amico G. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 62: 137–146, 2002.
15. Schaier M, Vorwalder S, Sommerer C, Dikow R, Hug F, Gross ML, Waldherr R, Zeier M. Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats. Am J Physiol Renal Physiol 297: F769–F780, 2009.
16. Strutz F, Muller GA. Renal fibrosis and the origin of the renal fibroblast. Nephrol Dial Transplant 21: 3368–3370, 2006.
17. Suthanthiran M, Muthukumar T. Urinary-cell mRNA and acute kidney-transplant rejection. N Engl J Med 369: 1860–1861, 2013.
18. Suthanthiran M, Schwartz JE, Ding R, Abecassis M, Dadhania D, Samstein B, Knechtle SJ, Friedewald J, Becker YT, Sharma VK, Williams NM, Chang CS, Hoang C, Muthukumar T, August P, Keslar KS, Fairchild RL, Hricik DE, Heeger PS, Han L, Liu J, Riggs M, Ikle DN, Bridges ND, Shaked A. Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med 369: 20–31, 2013.
19. Szeto CC, Chan RW, Lai KB, Szeto CY, Chow KM, Li PK, Lai FM. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases. Nephrol Dial Transplant 20: 105–113, 2005.
20. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 139: 871–890, 2009.
21. Whittier WL, Korbet SM. Renal biopsy: update. Curr Opin Nephrol Hypertens 13: 661–665, 2004.
22. Wickman L, Afshinnia F, Wang SQ, Yang Y, Wang F, Chowdhury M, Graham D, Hawkins J, Nishizono R, Tanzer M, Wiggins J, Escobar GA, Rovin B, Song P, Gipson D, Kershaw D, Wiggins RC. Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases. J Am Soc Nephrol 24: 2081–2095, 2013.
23. Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 18: 1028–1040, 2012.
24. Zheng M, Lv LL, Cao YH, Liu H, Ni J, Dai HY, Liu D, Lei XD, Liu BC. A pilot trial assessing urinary gene expression profiling with an mRNA array for diabetic nephropathy. PLoS One 7: e34824, 2012.
25. Zheng M, Lv LL, Cao YH, Zhang JD, Wu M, Ma KL, Phillips AO, Liu BC. Urinary mRNA markers of epithelial-mesenchymal transition correlate with progression of diabetic nephropathy. Clin Endocrinol (Oxf) 76: 657–664, 2012.
26. Zheng M, Lv LL, Ni J, Ni HF, Li Q, Ma KL, Liu BC. Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy. PLoS One 6: e20431, 2011.